According to Fortune Business Insights, the global Transradial Access Devices Market was valued at USD 2.49 billion in 2025 and is projected to grow from USD 2.68 billion in 2026 to USD 4.93 billion by 2034, registering a CAGR of 7.91% during 2026–2034. Rising adoption of minimally invasive cardiovascular procedures, increasing prevalence of cardiovascular diseases, and technological advancements in vascular access devices are supporting market growth.
Transradial access devices are increasingly used in angiography, angioplasty, and catheterization procedures. Compared with femoral access, transradial procedures can reduce bleeding complications, support faster recovery, and improve patient mobility. Growing demand for advanced catheters, guidewires, and vascular access technologies is further strengthening adoption across hospitals and cardiac care centers.
The increasing prevalence of coronary artery disease, hypertension, peripheral vascular disorders, and other cardiovascular conditions is driving demand for diagnostic and interventional procedures. As the number of angiography and catheterization procedures increases, healthcare providers are adopting transradial access technologies to support minimally invasive cardiovascular interventions.
Hospitals are also placing greater emphasis on shorter hospitalization periods and patient recovery. Technological improvements in catheters, guidewires, and vascular access systems are helping physicians perform procedures with greater control and efficiency.
A major trend in the market is the increasing preference for minimally invasive cardiovascular procedures and same-day discharge models. Transradial access can facilitate earlier patient mobility following cardiac interventions, supporting its adoption in hospitals and specialty clinics.
Manufacturers are also developing hydrophilic guidewires, thin-wall catheters, and advanced hemostatic compression systems. Imaging-guided catheterization and robotic-assisted interventions are emerging alongside these device innovations, creating demand for more precise vascular access technologies.
For detailed market insights, visit: https://www.fortunebusinessinsights.com/transradial-access-devices-market-117418
The expansion of outpatient cardiovascular care is creating opportunities for manufacturers of transradial access devices. Healthcare providers are increasingly investing in ambulatory cardiovascular facilities and catheterization laboratories to improve procedural efficiency and manage growing patient volumes.
Emerging economies also represent an important opportunity as governments and private healthcare organizations expand cardiac care infrastructure. Investments in minimally invasive technologies, physician training, advanced imaging, and interventional cardiology programs can support broader adoption of transradial procedures.
Based on product, the market is divided into catheters and guidewires. Catheters accounted for approximately 57% of the market, making them the leading product segment. Their essential role in angiography, angioplasty, and interventional cardiovascular procedures supports continued demand.
Guidewires represented approximately 43% of the market. Growing adoption of steerable, hydrophilic, and specialty guidewires for complex vascular navigation is supporting this segment.